The bioavailability of nicorandil after oral administration of a single dose of 10 or 20 mg preparations
Molinaro, M.; Villani, P.; Buggia, I.; Iacona, I.; Zoia, C.; Regazzi, M.B.; Rondanelli, R.
Bollettino Chimico Farmaceutico 131(10): 375-379
1992
ISSN/ISBN: 0006-6648 PMID: 1296701 Document Number: 401812
Document emailed within 1 workday
Related Documents
Molinaro, M.; Villani, P.; Buggia, I.; Iacona, I.; Zoia, C.; Regazzi, M.B.; Rondanelli, R. 1992: The bioavailability of nicorandil after oral administration of a single dose of 10 or 20 mg preparations Bollettino Chimico Farmaceutico 131(10): 375-379Janssen, T.J.; Guelen, P.J.; Vree, T.B.; Botterblom, M.H.; Valducci, R. 1988: Bioavailability of ambroxol sustained release preparations. Part II: Single and multiple oral dose studies in man Arzneimittel-Forschung 38(1): 95-97
Wetzelsberger, N.; Birkel, M.; Fuder, H.; Lücker, P.W.; Stiegler, S.; Scheithauer, S.; Thümmler, D. 1995: Relative bioavailability of DL-oxyfedrine HCl after single-dose oral administration of tablets as compared to equimolar solutions Methods and Findings in Experimental and Clinical Pharmacology 17(3): 185-191
Borgia, M.; Longo, A.; Lodola, E. 1989: Relative bioavailability of fosfomycin and of trometamol after administration of single dose by oral route of fosfomycin trometamol in fasting conditions and after a meal International Journal of Clinical Pharmacology Therapy and Toxicology 27(8): 411-417
Pannuti, F.; Camaggi, C.M.; Strocchi, E.; Giovannini, M.; Di Marco, A.R.; Costanti, B. 1982: Medroxyprogesterone acetate (MAP) relative bioavailability after single high-dose administration in cancer patients Cancer Treatment Reports 66(12): 2043-2049
Scheidel, B.; Blume, H.; Walter, K.; von Nieciecki, A.; Babej-Dölle, R.M. 1993: Biological availability of gastric juice-resistant coated diclofenac preparations. 1. Bioavailability study following a single administration of a multiple-unit formulation in comparison with a single-unit formulation Arzneimittel-Forschung 43(11): 1211-1215
Hasan, M.M.; Najib, N.M.; Muti, H. 1993: A comparative bioavailability study on two sustained-release formulations of diclofenac sodium following a single dose administration International Journal of Clinical Pharmacology Therapy and Toxicology 31(8): 387-391
Rau, R. 2005: Bioavailability of higher dose MTX comparing oral and subcutaneous administration in patients with RA Journal of Rheumatology 32(7): 1412; Author Reply 1412-3
Bagli, M.; Rao, M.L.; Höflich, G.; Kasper, S.; Langer, M.; Barlage, U.; Beneke, M.; Süverkrüp, R.; Möller, H.J. 1996: Pharmacokinetics of chlorprothixene after single intravenous and oral administration of three galenic preparations Arzneimittel-Forschung 46(3): 247-250
Wójcicki, J.; Gawrońska-Szklarz, B.; Baśkiewicz, Z.; Kałucki, K. 1980: Paracetamol pharmacokinetics after oral administration of a single dose in the form of tablets and syrup Acta Poloniae Pharmaceutica 37(3): 351-354
Kuhnz, W.; al-Yacoub, G.; Fuhrmeister, A. 1992: Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation Contraception 46(5): 455-469
Oofuvong, M.; Chanvej, L.; Thongsuksai, P. 2005: Single dose oral clonidine premedication does not enhance postoperative, single low dose epidural morphine analgesia in hysterectomy patients Journal of the Medical Association of Thailand 88(3): 358-363
Lagas, M.; Jonkman, J.H. 1985: Influence of food on the rate and extent of absorption of theophylline after single dose oral administration of a controlled release tablet International Journal of Clinical Pharmacology Therapy and Toxicology 23(8): 424-426
Gupta, K.C.; Paul, T.; Mehta, J.M.; Desai, N.K.; Sanghvi, B.; Sheth, U.K. 1976: Study of bioavailability of oral iron preparations Journal of Postgraduate Medicine 22(2): 94-99
Jundt, J.W.; Browne, B.A.; Fiocco, G.P.; Steele, A.D.; Mock, D. 1993: A comparison of low dose methotrexate bioavailability: oral solution, oral tablet, subcutaneous and intramuscular dosing Journal of Rheumatology 20(11): 1845-1849
Simoni, P.; Sabatini, L.; Baraldini, M.; Mirasoli, M.; Roda, A.; Roda, E. 2002: Pharmacokinetics and bioavailability of four modified-release ursodeoxycholic acid preparations for once-a-day administration International Journal of Clinical Pharmacology Research 22(2): 37-45
Odlind, V.; Weiner, E.; Victor, A.; Johansson, E.D. 1979: Plasma levels of norethindrone after single oral dose administration of norethindrone and lynestrenol Clinical Endocrinology 10(1): 29-38
Liao, L.; Hua, H.; Zhao, J.-N.; Luo, H.; Yang, A.-D. 2014: Pharmacokinetics and relative bioavailability of THC and THC-solid dispersion orally to mice at single dose Zhongguo Zhong Yao Za Zhi 39(6): 1101-1106
Dagrosa, E.E.; Hajdú, P.; Malerczyk, V.; de Looze, S.; Seeger, K.; Grötsch, H. 1987: Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration Clinical Therapeutics 10(1): 18-31
Tabbara, K.F.; Gee, S.S.; Alvarez, H. 1988: Ocular bioavailability of cyclosporine after oral administration Transplantation Proceedings 20(2 Suppl 2: 656-659